After founding one unicorn company this AI pioneer is doing it again

After founding the "Google for LLMs," You.com, Richard Socher's next company, Recursive AI, could automate AI research itself ...
Infosecurity Magazine

How Security Leaders Can Safeguard Against Vibe Coding Security Risks

Infosecurity outlines key recommendations for CISOs and security teams to implement safeguards for AI-assisted coding ...
The Next Web

LinkedIn is secretly scanning your browser for 6,000 extensions, and you weren’t told

LinkedIn runs a hidden JavaScript script called Spectroscopy that silently probes over 6,000 Chrome extensions and collects ...
Nasdaq

Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Insider Activity

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...
Morningstar

Recursion Pharmaceuticals Inc Class A RXRX

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Benzinga.com

Recursion Pharmaceuticals Stock Short Interest Report | NASDAQ:RXRX | Benzinga

Web site created using create-react-app Short interest in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) decreased during the last reporting period, falling from 173.17M to 168.52M. This put 34.3% of the ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...